Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Galectin Therapeutics Inc (GALT)
Galectin Therapeutics Inc (GALT) Financials

GALT Galectin Therapeutics Inc

2.02

0.09 (4.66%)

11 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-105.917	-175.055	-228.556	-70.221	-60.466	-85.956	-123.187	-181.085
Return on Equity (%)	-157.772	-357.857	-647.879	-82.284	-71.153	-262.792	235.423	93.46
Return on Invested Capital (%)	-151.588	-291.591	-359.129	-51.541	-67.439	-108.24	-195.22	-407.253
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.234	0.026	0.12	0.571	0.303	0.032	-0.391	-0.717
Earnings Per Share	-0.509	-0.374	-0.261	-0.253	-0.295	-0.373	-0.472	-0.529
Cash Per Share	0.35	0.065	0.143	0.595	0.339	0.482	0.226	0.303
Working Capital Per Share	0.274	0.018	0.117	0.569	0.301	0.399	0.092	0.142
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.488	-0.347	-0.241	-0.167	-0.293	-0.371	-0.471	-0.485
EBITDA Per Share	-0.488	-0.347	-0.241	-0.167	-0.293	-0.371	-0.471	-0.485
Free Cash Flow Per Share	-0.509	-0.374	-0.261	-0.253	-0.296	-0.374	-0.472	-0.529

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	32.91M	35.79M	41.19M	56.9M	57.08M	59.34M	59.43M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	59.43M	N/A	59.58M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	121.13M
Price to Earnings Ratio	-2.73
Price to Sales Ratio	0
Price to Cash Ratio	4.77
Price to Book Ratio	-2.03
Dividend Yield	-

Share Statistics

Shares Outstanding	62.76M
Average Volume (1 week)	933.84k
Average Volume (1 Month)	414.64k
52 Week Change	9.78%
52 Week High	4.2684
52 Week Low	1.555

More Ratios Coming Soon!

Galectin Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions